New Big Money Means The Chemours Company (CC) Investors Could Reap Benefit
549 institutions hold shares in The Chemours Company (CC), with 1.59M shares held by insiders accounting for 0.96% while institutional investors hold 78.04% of the
549 institutions hold shares in The Chemours Company (CC), with 1.59M shares held by insiders accounting for 0.96% while institutional investors hold 78.04% of the
68 institutions hold shares in VAALCO Energy Inc. (EGY), with 4.55M shares held by insiders accounting for 7.90% while institutional investors hold 47.44% of the
991 institutions hold shares in CDW Corporation (CDW), with 1.34M shares held by insiders accounting for 0.95% while institutional investors hold 95.44% of the company’s
89 institutions hold shares in Soleno Therapeutics Inc. (SLNO), with 13.01M shares held by insiders accounting for 16.32% while institutional investors hold 70.36% of the
1,188 institutions hold shares in Xilinx Inc. (XLNX), with 470.93k shares held by insiders accounting for 0.19% while institutional investors hold 83.20% of the company’s
87 institutions hold shares in Poseida Therapeutics Inc. (PSTX), with 24.65M shares held by insiders accounting for 39.69% while institutional investors hold 72.39% of the
282 institutions hold shares in Abercrombie & Fitch Co. (ANF), with 1.41M shares held by insiders accounting for 2.27% while institutional investors hold 99.46% of
175 institutions hold shares in Chico’s FAS Inc. (CHS), with 9.6M shares held by insiders accounting for 8.02% while institutional investors hold 87.78% of the
360 institutions hold shares in Change Healthcare Inc. (CHNG), with 1.17M shares held by insiders accounting for 0.38% while institutional investors hold 103.08% of the
34 institutions hold shares in OncoSec Medical Incorporated (ONCS), with 13.85M shares held by insiders accounting for 37.28% while institutional investors hold 18.26% of the